Mathew Maurer
Director, Amyloid · Vagelos College of Physicians and Surgeons
Credentials: · · · · ·
History
- Present
NewYork-Presbyterian Hospital/Columbia University Medical Center
NewYork-Presbyterian Hospital/Columbia University Medical Center
NewYork-Presbyterian Hospital/Columbia University Medical Center
Research
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
New England Journal of Medicine · 2018 · First of 23 authors · 2,246 citations
Extrapulmonary manifestations of COVID-19
Review · Nature Medicine · 2020 · 2,208 citations
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Circulation · 2016 · 1,659 citations
64 papers
51 papers
48 papers
36 papers
35 papers · 5 as a fellow
- AC
34 papers · 22 as a resident
34 papers
32 papers
Grants
- 2026–2030
Mosaic Loss of the Y Chromosome in Transthyretin (ATTR) Cardiac Amyloidosis
National Institute on Aging · R01
PI · $763.6K · Boston Medical Center
- 2025–2029
Screening for Cardiac Amyloidosis with a Blood Biomarker in Minority Populations – SCABB-MP
National Heart, Lung, and Blood Institute · R01
PI · $970K · Ut Southwestern Medical Center
- 2023–2028
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
National Institute on Aging · R01
Contact PI · $2.8M · Columbia University Health Sciences
- 2019–2025
SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear Imaging in Minority Populations)
National Heart, Lung, and Blood Institute · R01
Contact PI · $7.4M · Columbia University Health Sciences
Clinical trials
- 2023–2028
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Principal investigator · Recruiting
Columbia University
- 2022–2024
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
Principal investigator · Completed · Phase 2
Columbia University
- 2022–2024
High Calorie High Protein Nutrition Supplementation in Advanced Heart Failure
Principal investigator · Completed
Columbia University
- 2022–2023
SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
Principal investigator · Completed · Phase 4
Columbia University